Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocuSign

Peloton

Peloton's stock has fallen almost 97% from its all-time high, as losses have piled up. Align Technology's fundamentals remain strong, despite the stock losing 19% last month.

Is It Time to Buy the Nasdaq's Worst-Performing September Stocks?

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2023 financial results on Wednesday, October 25, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and.

Align Technology to Announce Third Quarter 2023 Results on October 25, 2023

Align Technology, Inc. shares saw a significant pullback in 2022 after a boom in 2021. The company's performance has stabilized, but the current valuation is not appealing. Align is on track to generate $4 billion in sales this year, but earnings power falls short of 2021 levels, and short of levels to see appeal here.

Align Technology: Expectations Run Hot(ter) Again

Here is how Align Technology (ALGN) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Align Technology (ALGN) This Year?

ALGN stock was trading at around $237 in early June 2022, just before the Fed started increasing rates, and is now 26% above that level, compared to 13% gains for the

Will Align Technology (ALGN) Stock Rebound To Its Pre-Inflation Shock Level Of Over $700?

CONMED

Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks is more attractive to value investors?

CNMD vs. ALGN: Which Stock Is the Better Value Option?

Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Down -14.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Align Technology (ALGN)

Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.

Align (ALGN) Gains From Growing Invisalign Volume, Innovation

Hawkins

Palo Alto Networks

Retail sales have surpassed analysts' expectations of a 0.1% increase this month, with a robust 0.6% growth instead. This growth rate surge is largely attributed to rising gasoline prices.

3 Nasdaq Stocks That Should Be on Every Investor's Radar This Fall

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2023 Invisalign GP Summit, the Company's premier clinical education and networking experience designed to help doctors transform.

Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share Best Practices for Leading Transformation in Dentistry

Here's Why Align Technology (ALGN) is Poised for a Turnaround After Losing -10.74% in 4 Weeks

Align Technologies (ALGN) introduces a series of software innovations to accelerate the digital practice transformation.

Align Technologies (ALGN) Brings New Upgrades for Oral Health

Align Technologies (ALGN) announces acquisition of direct 3D printing pioneer Cubicure GmbH, backed by years of successful collaboration.

Align Technologies (ALGN) Set to Acquire Cubicure GmbH

Align Technology's (ALGN) introduction of the new SmartForce feature is expected to minimize the number of attachments while maintaining predictable treatment outcomes.

Align Technology's (ALGN) New Feature to Boost Patient Experience

TORONTO & LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its customer education and training center in Toronto, Canada to promote professional engagement and training about Invi.

Align Technology Launches Customer Education and Training Center in Toronto, Canada

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced Plan Editor in ClinCheck® treatment planning software, a new tool in the Align digital workflow built into the Align Digital Platform™. The Alig.

Align Technology Introduces Invisalign® System Innovation for Greater Control of Digital Treatment Planning With Integration of Plan Editor Into ClinCheck® Treatment Planning Software

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced a new SmartForce feature, attachment-free aligner activation, that helps minimize the number of attachments while maintaining predictable treatm.

Align Technology Introduces New SmartForce™ Attachment-free Aligner Activation Feature

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz. & VIENNA--(BUSINESS WIRE)--Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced that it has entered into a definitive agreement to acquire privately held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and processes for novel 3D printing solutions. Cubicure's patented Hot Lithography technology uses a special heating and coati.

Align Technology to Acquire Privately Held Direct 3D Printing Pioneer Cubicure to Support and Scale Company's Strategic Innovation Roadmap

TORONTO & LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced the Invisalign® Palatal Expander System,* a modern and innovative direct 3D printed device based on a proprietary and patented techno.

Align Technology Introduces the Invisalign® Palatal Expander System to Address Skeletal Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced a new doctor enabled direct ship to patient feature in its Vivera™ Retainer Subscription (VRS) platform that allows doctors to have subsequent.

Align Technology Introduces New Vivera Retainer Doctor Enabled Direct Ship to Patient Feature in Its Doctor Subscription Program

LAS VEGAS & PETACH TIKVA, Israel & SAN JOSE, Calif. & TEMPE, Ariz..--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today introduced new software innovations to accelerate digital practice transformation. The Align™Oral Health Suite is an intuitive and v.

Align Technology Introduces New Software Innovations Designed to Accelerate Digital Practice Transformation

Artificial intelligence is exciting, but there are also big opportunities in healthcare, specifically in the market for clear aligners. Align Technology is a big company in that space, and its growth rate picked up this year.

This Healthcare Stock Has Been a Hotter Buy Than Amazon and Alphabet This Year

Align Technology has a first-mover advantage in the clear aligner market and a solid competitive position. The risk-reward is balanced with a modest upside from the current valuation. Align has enduring competitive advantages, including switching costs and intellectual property, but faces competition from well-respected players in the dental market.

Align Technology: Commanding Position But Balanced Risk-Reward

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that on August 21, 2023, the Superior Court, State of California, County of Santa Clara issued an order granting Align's petition to confirm and denying SmileDirectClub LLC (“SDC”) peti.

Superior Court of California, County of Santa Clara, Confirms $63 Million Arbitration Award in Favor of Align Technology and Denies SmileDirectClub's Motion to Vacate

Align Technology (ALGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

News for Align Technology Stock (ALGN)